Scientists found one dosing regimen may actually provide 90% protection against Covid-19.
The vaccine is being made in India with Adar Poonawalla's Serum Institute.
The health minister reiterated the government’s plan was to immunise 200 million to 250 million Indians by July.
The University of Oxford is expected to release data on the effectiveness of its coronavirus jab in the coming weeks.
Figuring out what’s needed to achieve herd immunity with Covid-19 vaccines involves a range of factors, several of which are unknown.
"The risk of having a severe outcome from Covid-19 far outweighs any theoretical risk of a vaccine," Robin Shattock told BBC Question Time.
Infectious disease pros share what makes them hopeful, what has them concerned and other takeaways from the coronavirus vaccine news.
Here's what we may see with the coronavirus next year, from wearing face masks to a vaccine.
From safety concerns to how it actually works, a quick guide to the vaccine everyone's talking about.
Here's what we may see with the coronavirus next year, from wearing face masks to a vaccine.
Pfizer and German partner BioNTech SE are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine.
Bharat Biotech, a private company that is developing COVAXIN with ICMR, had earlier hoped to launch it only in the second quarter of next year.
“As soon as COVID-19 vaccine will be available for production at mass scale, every person in Bihar will get free vaccination,” the Union Finance Minister said.
CNN Brasil reported that the volunteer was a 28-year-old man who lived in Rio de Janeiro and died from COVID-19 complications.
Experts can say "with confidence" that parents should expect a delay.
The plan, which is still in the draft stage, aims to cover 23% of the population in the first phase.
Kang also talks about a realistic timeline for vaccine availability, the challenges of vaccine distribution and the funds required for the process.
Union Health Minister also said that the Feluda paper strip test could be rolled out in the next few weeks.
Nine experimental vaccines are in the pipeline of the WHO’s COVAX global vaccine facility that aims to distribute 2 billion doses by the end of 2021.
"Our rough estimate and the target would be to receive and utilise 400 to 500 million doses covering approximately 25 crore people by July 2021," Harsh Vardhan said.